Export 4 results:
Author Title Type [ Year(Asc)]
Filters: Author is Srivastava, Alok and Keyword is Genetic Therapy  [Clear All Filters]
2023
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL.  2023.  International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.. Cytotherapy. 25(9):920-929. DOI:10.1016/j.jcyt.2023.03.002.
2022
Karuppusamy KV, Demosthenes JPaul, Venkatesan V, Christopher ACrystal, Babu P, Azhagiri MK, Jacob A, Ramalingam VVadhini, Rangaraj S, Murugesan MKumarasamy, Marepally SKumar, Varghese GM, Srivastava A, Kannangai R, Thangavel S.  2022.  The CCR5 Gene Edited CD34(+)CD90(+) Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.. Front Immunol. 13:792684. DOI:10.3389/fimmu.2022.792684.
Reiss UM, Mahlangu J, Ohmori T, Ozelo MC, Srivastava A, Zhang L.  2022.  Haemophilia gene therapy-Update on new country initiatives.. Haemophilia. 28 Suppl 4:61-67. DOI:10.1111/hae.14512.
Christopher ACrystal, Venkatesan V, Karuppusamy KV, Srinivasan S, Babu P, Azhagiri MKumar K, Chambayil K, Bagchi A, Rajendiran V, Ravi NSam, Kumar S, Marepally SKumar, Mohankumar KMurugesan, Srivastava A, Velayudhan SR, Thangavel S.  2022.  Preferential Expansion of Human CD34CD133CD90 Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy.. Hum Gene Ther. 33(3-4):188-201. DOI:10.1089/hum.2021.089.